- Investing Ideas
- /
- Brazilian Potentially Undervalued Companies
Brazilian Potentially Undervalued Companies
UPDATED Apr 12, 2024
Companies with a Value score of at least 3, ordered by Value score
381 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
D2KN34 | US$37.72 | -5.5% | 143.7% | US$21.6b | US$43.58 | PS5.7x | E60.0% | n/a | Consumer Services | ||
LEVE3 | R$34.24 | 0.7% | 12.4% | R$4.8b | R$31.33 | PE6.2x | E-9.0% | 18.6% | Automobiles | ||
FRAS3 | R$17.63 | 1.0% | 90.6% | R$4.7b | R$21.79 | PE12.5x | E6.0% | 2.7% | Automobiles | ||
JSLG3 | R$13.15 | -0.2% | 78.7% | R$3.7b | R$15.66 | PE10.6x | E21.0% | 2.4% | Transportation | ||
C2OL34 | Col$44.45 | -2.7% | 31.2% | Col$34.0t | Col$43.69 | PB0.9x | E0.7% | 9.9% | Banks | ||
MRCK34 | US$80.17 | -1.1% | 13.5% | US$319.5b | US$87.45 | PE872.6x | E25.9% | 2.4% | Pharmaceuticals & Biotech | ||
B1CS34 | UK£47.85 | -3.1% | 23.6% | UK£27.5b | UK£62.16 | PB0.4x | E10.1% | 4.4% | Banks | ||
AURA33 | CA$40.70 | 2.2% | 0.5% | CA$798.9m | CA$51.33 | PE18.5x | E26.6% | 6.1% | Materials | ||
BRIT3 | R$4.07 | -8.1% | 76.2% | R$1.9b | R$6.26 | PE11.1x | E5.2% | 0.8% | Telecom | ||
CIEL3 | R$5.47 | 0.6% | 7.7% | R$14.6b | R$5.38 | PE7.1x | E-1.4% | 5.2% | Diversified Financials | ||
N1VS34 | CHF47.88 | -1.4% | -1.3% | CHF188.6b | CHF54.85 | PE24.1x | E9.1% | 3.8% | Pharmaceuticals & Biotech | ||
TOTS3 | R$27.38 | -3.1% | 2.4% | R$16.6b | R$36.66 | PE32.6x | E25.3% | 1.6% | Software | ||
BILB34 | €54.00 | -10.3% | 53.4% | €56.3b | €56.39 | PB1.1x | E0.5% | 5.5% | Banks | ||
W1YN34 | US$210.54 | 0% | -25.4% | US$11.8b | US$243.21 | PE16.2x | E-0.2% | 0.9% | Consumer Services | ||
BAZA9 | R$51.00 | 1.5% | n/a | R$1.5b | n/a | PB0.3x | n/a | 13.3% | Banks | ||
I2CM34 | US$28.91 | 0% | n/a | US$2.2b | US$43.26 | PB1.1x | E68.0% | n/a | Healthcare | ||
V2MW34 | US$71.30 | 1.6% | 47.0% | US$71.7b | US$68.19 | PE50.3x | E14.3% | n/a | Software | ||
E2NO34 | US$66.47 | 0% | n/a | US$3.2b | US$84.15 | PS1.9x | E83.1% | n/a | Healthcare | ||
T1FX34 | US$109.30 | 0% | -17.9% | US$10.2b | US$132.89 | PE28.6x | E14.9% | 0.6% | Healthcare | ||
R2AR34 | US$23.38 | 0% | n/a | US$4.2b | US$41.53 | PS9.6x | E48.9% | n/a | Pharmaceuticals & Biotech | ||
R2RX34 | US$46.80 | 0% | n/a | US$11.1b | US$55.76 | PS1.7x | E96.6% | 0.9% | Capital Goods | ||
E1LV34 | US$499.00 | 0% | 3.0% | US$116.8b | US$579.07 | PE19.3x | E12.5% | 1.3% | Healthcare | ||
AIRB34 | US$40.79 | -0.2% | 45.7% | US$105.3b | US$38.10 | PE21.2x | E0.5% | n/a | Consumer Services | ||
CSUD3 | R$19.01 | -5.0% | 75.9% | R$794.2m | R$22.00 | PE8.9x | E14.6% | 3.4% | Diversified Financials |